Peter J Nash

Title: Peter J Nash: Innovator in Filovirus Therapeutics

Introduction

Peter J Nash is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of therapeutics, particularly in the development of treatments for filovirus infections. His innovative work has the potential to impact public health positively.

Latest Patents

Peter J Nash holds a patent for "Broad spectrum inhibitors of filoviruses." This invention focuses on creating therapeutics and prophylactics aimed at treating and preventing filovirus infections in humans and other mammals. The patent discloses a new class of small molecules that inhibit the interaction between the filovirus glycoprotein and its host receptor, Niemann-Pick C1 protein. This mechanism effectively blocks the infection of host cells by filoviruses. Additionally, the patent outlines methods for utilizing these small molecule inhibitors in the treatment and prevention of filovirus infections.

Career Highlights

Throughout his career, Peter has worked with various organizations, including Microbiotix, Inc. and Albert Einstein College of Medicine. His experience in these institutions has allowed him to collaborate with other experts in the field and further his research on filoviruses.

Collaborations

Peter has collaborated with notable colleagues such as Terry L Bowlin and Donald T Moir. These partnerships have contributed to the advancement of his research and the development of innovative solutions for combating filovirus infections.

Conclusion

Peter J Nash is a dedicated inventor whose work in filovirus therapeutics showcases his commitment to improving health outcomes. His patent and collaborations highlight the importance of innovation in addressing critical health challenges.